Hepatitis B virus haplotype number at baseline is a predictive marker of functional cure during antiviral therapy for patients with genotypes A and D <scp>HBeAg</scp> ‐positive chronic hepatitis B-Reference-Cited by-同舟云学术

Hepatitis B virus haplotype number at baseline is a predictive marker of functional cure during antiviral therapy for patients with genotypes A and D HBeAg ‐positive chronic hepatitis B

Published:2022-11-25 Issue:5 Volume:57 Page:509-523
ISSN:0269-2813
Container-title:Alimentary Pharmacology & Therapeutics
language:en
Short-container-title:Aliment Pharmacol Ther

Author:

Wagner Josef¹²,Yuen Lilly¹³,Littlejohn Margaret¹,Sozzi Vitina¹,Jackson Kathy¹,Martin Ross⁴,Aeschbacher Thomas⁴,Suri Vithika⁴,Tan Susanna K.⁴,Feierbach Becket⁴,Gaggar Anuj⁴,Marcellin Patrick⁵,Buti Ferret Maria⁶,Janssen Harry L. A.⁷,Gane Ed⁸,Meagher Niamh³,Price David J.³⁹,Wong Darren¹¹⁰,Thompson Alexander T.¹⁰,Revill Peter A.¹³¹¹^ORCID

Affiliation:

1. Victorian Infectious Diseases Reference Laboratory Royal Melbourne Hospital at the Peter Doherty Institute for Infection and Immunity Melbourne Victoria Australia

2. Department of Paediatrics University of Melbourne Melbourne Victoria Australia

3. Department of Infectious Diseases University of Melbourne at the Peter Doherty Institute for Infection and Immunity Melbourne Victoria Australia

4. Gilead Sciences Foster City California USA

5. Hôpital Beaujon University of Paris Clichy France

6. Liver Unit Valle d'Hebron (Ciberehd) University Hospital Barcelona Spain

7. Toronto Center for Liver Diseases, Toronto General Hospital, University: Health Network University of Toronto Toronto Ontario Canada

8. New Zealand Liver Transplant Unit Auckland City Hospital Auckland New Zealand

9. Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health The University of Melbourne Melbourne Victoria Australia

10. Department of Gastroenterology St. Vincent's Hospital Melbourne Victoria Australia

11. Department of Microbiology and Immunology University of Melbourne at the Peter Doherty Institute for Infection and Immunity Melbourne Victoria Australia

Funder

Gilead Sciences

Publisher

Wiley

Subject

Pharmacology (medical),Gastroenterology,Hepatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/apt.17299

Reference36 articles.

1. World Health Organization.Progress report on HIV viral hepatitis and sexually transmitted infections 2021: accountability for the global health sector strategies 2016–2021: actions for impact [Internet].2021. Available from:https://www.who.int/publications/i/item/9789240027077. Accessed 1 Jun 2022.

2. World Health Organization.Hepatitis B.2021. Available from:https://www.who.int/news‐room/fact‐sheets/detail/hepatitis‐b. Accessed 1 Jun 2022.

3. How Do We Determine Whether a Functional Cure for HBV Infection Has Been Achieved?

4. Durability of Spontaneous and Treatment-Related Loss of Hepatitis B s Antigen

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. VILOCA: Sequencing quality-aware haplotype reconstruction and mutation calling for short- and long-read data;2024-06-09

2. Editorial: baseline hepatitis B virus haplotype number may help predict a functional cure in patients with chronic hepatitis B treated with nucleotide analogues—authors' reply;Alimentary Pharmacology & Therapeutics;2023-02-14

3. Editorial: baseline hepatitis B virus haplotype number may help predict a functional cure in patients with chronic hepatitis B treated with nucleotide analogues;Alimentary Pharmacology & Therapeutics;2023-02-14